A Study to Evaluate the Safety and Immunogenicity of MEDI7510 in Older Adults
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Craig Curtis, MD
Compass Research
Principal Investigator - Eric Sheldon, MD
Miami Research Associates
Principal Investigator - H. Keipp Talbot, MD
Vanderbilt University Medical Center
Principal Investigator - John Ervin, MD
The Center for Pharmaceutical Research
Principal Investigator - Judith Falloon, MD
MedImmune LLC
Study Director - Wayne Harper, MD
Wake Research Associates
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Orlando, Florida, United States
- Research Site
South Miami, Florida, United States
- Research Site
Kansas City, Missouri, United States
- Research Site
Raleigh, North Carolina, United States
- Research Site
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Jan 2015
- Primary completion
- 24 Feb 2016
- Completion
- 24 Feb 2016
- Last update posted
- 15 Mar 2018
- Registered enrollment
- 363
- Registry id
- NCT02289820
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.